Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Rev. neurol. (Ed. impr.) ; 67(12): 484-490, 16 dic., 2018. graf, tab
Article in Spanish | IBECS | ID: ibc-175178

ABSTRACT

Introducción. Las meningitis víricas representan una entidad relativamente frecuente en los recién nacidos, aunque en muchos casos infradiagnosticadas, ante la ausencia de pleocitosis en el líquido cefalorraquídeo (LCR). Objetivos. Describir las características clínicas y los hallazgos de laboratorio de neonatos con meningitis víricas y destacar la importancia de la reacción en cadena de la polimerasa (PCR) en el LCR para diagnosticar esta patología. Pacientes y métodos. Revisión retrospectiva de historias clínicas de neonatos ingresados en la sección de neonatología diagnosticados de meningitis vírica entre mayo de 2014 y mayo de 2017. Resultados. Se registraron 17 casos de meningitis vírica (15 causadas por enterovirus y dos por parecho virus), que constituyenel 14,8% de los neonatos ingresados por síndrome febril. Todos manifestaron fiebre (100%), y otros síntomas destacados fueron irritabilidad (76%) y rechazo de la ingesta (65%). El 88% cursó con celularidad normal en el LCR y sin hiperproteinorraquia, y el 100%, sin hipoglucorraquia, por lo que previamente muchos de estos niños quedaban con el diagnóstico de síndrome febril sin foco. Estos datos resaltan la necesidad de realizar la PCR en el LCR a neonatos con fiebre sin foco, debido a la normalidad de las pruebas complementarias en la mayoría de los casos. El 64,7% de los niños recibió seguimiento neurológico posterior en consulta de neurología, sin objetivarse secuelas neurológicas, salvo en uno de ellos. Conclusiones. La PCR múltiple en el LCR se ha convertido en una técnica diagnóstica imprescindible en el recién nacido con sospecha de infección, y sustituye al cultivo viral como prueba de referencia por su mayor rapidez y sensibilidad


Introduction. The different types of viral meningitis constitute a condition that is relatively frequent in newborn infants, although in many cases they are underdiagnosed due to the absence of pleocytosis in the cerebrospinal fluid (CSF). Aims. To describe the clinical features and laboratory findings of newborn infants with viral meningitis and to highlight the importance of the polymerase chain reaction (PCR) in the CSF to diagnose this condition. Patients and methods. A retrospective review of the medical records of newborn infants hospitalised in the neonatology section who had been diagnosed with viral meningitis between May 2014 and May 2017. Results. Altogether 17 cases of viral meningitis were registered (15 caused by enterovirus and two due to parechovirus), which accounts for 14.8% of all newborns hospitalised owing to febrile symptoms. All of them had fever (100%), and other notable symptoms were irritability (76%) and rejection of feeding (65%). Normal cellularity was found in the CSF without high protein levels in 88% of them, and without hypoglycorrhachia in all of them (100%), which meant that many of these children had previously been left with a diagnosis of a febrile syndrome with no focus. These data stress the need to perform the PCR in the CSF of newborn infants who have a fever without a focus, due to the normal status of the results of the complementary tests in most cases. Subsequent neurological follow-up was performed in 64.7% of the children in the neurology service, without any neurological sequelae being found, except in one case. Conclusions. Multiple PCR in the CSF has become an essential diagnostic technique in cases of newborn infants with a suspected infection, and replaces viral culture as the reference test due its being quicker and more sensitive


Subject(s)
Humans , Male , Pregnancy , Infant, Newborn , Infant, Newborn, Diseases/virology , Infant, Newborn, Diseases/diagnosis , Cerebrospinal Fluid/virology , Meningitis, Viral/diagnosis , Polymerase Chain Reaction , Retrospective Studies
2.
Neuromuscul Disord ; 27(2): 188-192, 2017 Feb.
Article in English | MEDLINE | ID: mdl-28040389

ABSTRACT

We report the case of a newborn with arthrogryposis multiplex congenita and severe axial hypotonia without cardiac involvement in which, using a customized targeted next-generation sequencing assay for 64 myopathy-associated genes, we detected a novel homozygous truncating mutation, c.38661_38665del, in exon 197 of the TTN gene that is expressed only in the fetal skeletal isoform. Its pathogenicity is supported by evidence of maternal isodisomy for chromosome 2. Muscle pathology showed fibers with core-like areas devoid of oxidative staining and cytoplasmic bodies. Electron microscopy showed the replacement of the sarcomeric structure with filamentous material. Identification of this mutation expands the phenotypic spectrum of the TTN gene and shows for the first time that a mutation not found in adult TTN isoforms is involved in the development of a neuromuscular disorder. TTN mutations should be considered in all severe congenital myopathies with arthrogryposis without cardiac involvement.


Subject(s)
Arthrogryposis/genetics , Connectin/genetics , Muscular Diseases/genetics , Humans , Infant, Newborn , Muscular Diseases/congenital , Mutation , Protein Isoforms
3.
Rev. neurol. (Ed. impr.) ; 63(4): 160-164, 16 ago., 2016.
Article in Spanish | IBECS | ID: ibc-155476

ABSTRACT

Introducción. La leucinosis es una metabolopatía neonatal grave. Es consecuencia del déficit enzimático determinado genéticamente del complejo descarboxilasa-dihidrolipoil transacilasa y dihidrolipoil deshidrogenasa, y del acúmulo consecuente de los metabolitos precursores, aminoácidos ramificados de cadena larga y sus alfa-cetoácidos. Son potentes neurotóxicos, responsables del rápido establecimiento de edema y desmielinización cerebral difusa. La demora en el diagnóstico suele provocar graves secuelas psicomotoras o incluso la muerte. Caso clínico. Se presenta una paciente neonata con encefalopatía neonatal grave, crisis epilépticas y un electroencefalograma (EEG) con unas características especiales que orientó el diagnóstico hacia una posible leucinosis. El diagnóstico temprano permitió instaurar rápidamente el tratamiento específico y conseguir una evolución favorable de la paciente. Conclusiones. El EEG en pacientes con sospecha de encefalopatía neonatal ofrece información funcional de alta rentabilidad con un bajo coste, en especial por promover diagnósticos y tratamientos tempranos. El EEG en la leucinosis presenta signos peculiares, reconocibles en períodos tempranos en la mayor parte de los afectados, como ocurrió en el caso descrito. Parece recomendable integrar el EEG en el cribado de encefalopatías neonatales por ser una técnica diagnóstica valiosa, inocua y, por lo general, accesible y especialmente de ayuda en metabolopatías tratables, como la leucinosis (AU)


Introduction. Leucinosis is a severe neonatal metabolic disease. It is the consequence of the genetically determined enzyme deficiency of the complex formed by decarboxylase-dihydrolipoyl transacylase and dihydrolipoyl dehydrogenase, and of the subsequent accumulation of precursor metabolites, long branched-chain amino acids and their alpha ketoacids. They are powerful neurotoxins, responsible for the swift onset of oedema and diffuse cerebral demyelination. Delays in its diagnosis usually result in severe psychomotor sequelae or even death. Case report. We report the case of a newborn female patient with severe neonatal encephalopathy, epileptic seizures and an electroencephalogram (EEG) with certain special characteristics that guided the diagnosis towards that of possible leucinosis. Early diagnosis makes it possible to establish specific treatment and achieve a favourable patient outcome. Conclusions. An EEG in patients with suspected neonatal encephalopathy offers highly cost-effective functional information at a low cost, especially because it promotes early diagnoses and treatments. In cases of leucinosis, EEG presents peculiar signs that are easily recognisable in early periods in most patients, as occurred in the case reported here. We believe EEG should be included in screening for neonatal encephalopathies because it is a valuable, innocuous and generally accessible diagnostic technique. It is especially helpful in treatable metabolic diseases, such as leucinosis (AU)


Subject(s)
Humans , Female , Infant, Newborn , Maple Syrup Urine Disease/complications , Maple Syrup Urine Disease/therapy , Maple Syrup Urine Disease , Electroencephalography/instrumentation , Electroencephalography/methods , Electroencephalography , Brain Diseases/complications , Brain Diseases , Leucine/analysis , Leucine/blood , Muscle Hypotonia/complications , Magnetic Resonance Spectroscopy/methods , Mesencephalon , Cerebrum
4.
Neuromuscul Disord ; 25(3): 222-4, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25578555

ABSTRACT

Spinal muscular atrophy and progressive myoclonic epilepsy (SMAPME, OMIM#159950) is a rare autosomal recessive disorder characterized by the combination of progressive myoclonic epilepsy and muscular weakness due to lower motor neuron disease. Mutations in ASAH1, previously associated only to Farber disease, have been recently described in seven patients with SMAPME. A homozygous c.125C>T mutation was initially found in six patients with a clinical homogeneous phenotype. A heterozygous compound mutation found in an additional patient has broadened the clinical and genetic spectrum of clinical SMAPME. We report a new case of a 13-year-old girl with SMAPME with the homozygous ASAH1 c.125C>T mutation, unique in that it is due to paternal uniparental disomy. She experienced muscle weakness from the age of three due to lower motor neuron involvement that lead to severe handicap and onset in late childhood of a progressive myoclonic epilepsy. This clinical picture fully overlaps with that of previously reported patients with this mutation and supports our view that the clinical phenotype associated with the homozygous c.125C>T mutation constitutes a clinically homogenous and recognizable disease.


Subject(s)
Acid Ceramidase/genetics , Muscular Atrophy, Spinal/genetics , Muscular Atrophy, Spinal/physiopathology , Myoclonic Epilepsies, Progressive/genetics , Myoclonic Epilepsies, Progressive/physiopathology , Uniparental Disomy , Adolescent , Chromosomes, Human, Pair 8 , Female , Haplotypes , Homozygote , Humans , Muscular Atrophy, Spinal/etiology , Mutation , Myoclonic Epilepsies, Progressive/etiology , Phenotype
5.
Am J Med Genet A ; 158A(4): 877-81, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22407779

ABSTRACT

A newborn boy with broad forehead, mild microretrognathia, large hands and feet, arachnodactyly and a cortical thumb also had left renal agenesis, dysgenesis of corpus callosum with psychomotor delay. After olignucleotide array comparative genomic hybridization (array-CGH) analysis, we detected a 900 kb duplication in cytoband 5p13.2, apperently a first clinical description.


Subject(s)
Abnormalities, Multiple/genetics , Chromosome Duplication/genetics , Chromosomes, Human, Pair 5/genetics , Excitatory Amino Acid Transporter 1/genetics , Agenesis of Corpus Callosum/genetics , Arachnodactyly/genetics , Comparative Genomic Hybridization , Congenital Abnormalities/genetics , DNA Copy Number Variations , Genetic Testing/methods , Humans , Infant, Newborn , Karyotype , Kidney/abnormalities , Kidney Diseases/congenital , Kidney Diseases/genetics , Male , Muscle Hypotonia/genetics , Phenotype , Psychomotor Performance , Retrognathia/genetics
6.
Rev Neurol ; 54(4): 241-8, 2012 Feb 16.
Article in Spanish | MEDLINE | ID: mdl-22314765

ABSTRACT

X-chromosome-linked ichthyosis is caused by mutation or deletion of the STS gene associated with a deficiency of the enzyme steroid sulphatase, located in the distal part of the short arm of the X chromosome (Xp22.3-pter), close to the pseudo-autosomal region. Depending on its size, it can present as an isolated entity or combined with a syndrome caused by neighbouring genes, thus associating itself with other monogenic diseases as well as other mental disorders. The most relevant findings from the literature review are the importance of the Xp22.3-pter region and the higher incidence of neurological disorders among males (attention deficit hyperactivity disorder, autism and X-linked mental retardation). The role and implication of these genes in the disease are discussed and the authors suggest a possible contribution of the gene PNPLA4, which was originally described as GS2 and codes for calcium-independent phospholipase A2 beta, involved in lipoprotein metabolism, as one of the causes of autism. Improvements have been observed following treatment with citicoline, thanks to the role this nootropic plays in the biosynthesis of structural phospholipids involved in the formation and repair of the neuronal membrane.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Autistic Disorder/genetics , Chromosome Deletion , Epilepsy/genetics , Ichthyosis, X-Linked/genetics , Mental Retardation, X-Linked/genetics , Chromosome Mapping , Humans , Ichthyosis, X-Linked/pathology , Ichthyosis, X-Linked/physiopathology
7.
Rev. clín. med. fam ; 4(2): 162-165, 2011. ilus
Article in Spanish | IBECS | ID: ibc-90846

ABSTRACT

El síndrome triple XXX es una anomalía cromosómica relativamente frecuente, con una incidencia de 1 por cada 1.000 ó 1.200 recién nacidas vivas, en relación generalmente a edad materna elevada. Sin embargo, no suele sospecharse al nacimiento al no presentar un fenotipo característico y, aunque el dismorfismo puede ser muy variable, lo habitual es que no presenten ninguna manifestación clínica. Es por esto que el diagnóstico, con frecuencia, se establece tardíamente tras la presentación de insuficiencia ovárica primaria. Sólo en pocas ocasiones se describe en la literatura dismorfismo facial y otras malformaciones asociadas, sobre todo a nivel de aparato genitourinario, como genitales ambiguos, disgenesia ovárica, extrofia de cloaca, agenesia renal y con menor frecuencia cardiopatías u otras. El pronóstico es variable, dependiendo de la severidad de las anomalías presentadas, aunque hay casos descritos con retraso mental. Lo más frecuente es que tengan una inteligencia normal o ligeramente inferior a la normal. Presentamos el caso de una niña diagnosticada en periodo neonatal por un síndrome polimalformativo, en la cual se han encontrado anomalías poco habituales en este síndrome, como un dismorfismo facial peculiar, la implantación anómala del pulgar, la hipoacusia bilateral y una cardiopatía congénita. También presenta, como hallazgos más frecuentes en este síndrome, retraso psicomotor y del lenguaje. Destacamos la importancia del diagnóstico precoz para la instauración temprana del tratamiento(AU)


The triple X syndrome is a relatively common chromosome abnormality, with an incident of 1 per 1,000 or 1,200 live new born infants, generally related to advanced maternal age. However, it is not usually suspected at birth due to the lack of a characteristic phenotype and, although dysmorphism may be variable, there is usually no clinical manifestation. This is why diagnosis is often delayed until after the presentation of primary ovary failure. Facial dysmorphism and other related malformations, especially of genitourinary system, such as ambiguous genitalia, ovarian dysgenesis, cloacal exstrophy, renal agenesis and less frequently heart diseases or other diseases, have been rarely reported in the literature. The prognosis is variable, depending on the severity of the abnormalities, although cases of mental retardation have been described. Most patients have normal or slightly below normal intelligence. We report a case of a girl diagnosed in the neonatal period with polymalformation syndrome, which included rare abnormalities, such as a peculiar facial dysmorphism, abnormal implantation of the thumb, bilateral hearing loss and congenital heart disease. The more common findings in this syndrome were also present such as psychomotor and language retardation. We emphasise the importance of early diagnosis for prompt installation of treatment(AU)


Subject(s)
Humans , Female , Child , Trisomy/diagnosis , Trisomy/genetics , Chromosome Disorders/diagnosis , Chromosome Disorders/genetics , Language Development Disorders/complications , Language Development Disorders/diagnosis , Trisomy/physiopathology , Psychomotor Performance/physiology , Language Development Disorders/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL